7 The use of gonadotrophin-releasing hormone antagonists in polycystic ovarian disease

Alcalay, 1995, Polycystic ovarian syndrome, pregnancy outcome following in vitro fertilization-embryo transfer, Gynecological Endocrinology, 9, 119, 10.3109/09513599509160200 Ashkenasi, 1995, Polycystic ovary syndrome patients as oocyte donors: the effect of ovarian stimulation protocol on the implantation rate of the recipient, Fertility and Sterility, 64, 564, 10.1016/S0015-0282(16)57793-0 Balen, 1993, Hypersecretion of luteinizing hormone: a significant cause of infertility and miscarriage, British Journal of Obstetrics and Gynaecology, 100, 1082, 10.1111/j.1471-0528.1993.tb15170.x Bouchard, 1994, The role of GnRH during the periovulatory period: a basis for the use of GnRH antagonists in ovulation induction, 291 Buckler, 1989, GnRH agonist administration in polycystic ovary syndrome, Clinical Endocrinology, 31, 151, 10.1111/j.1365-2265.1989.tb01238.x Buyalos, 1996, Polycystic ovary syndrome: pathophysiology and outcome with in vitro fertilization, Fertility and Sterility, 65, 1, 10.1016/S0015-0282(16)58017-0 Cedars, 1992, Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction, Fertility and Sterility, 57, 495, 10.1016/S0015-0282(16)54890-0 Charbonnel, 1987, Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins, Fertility and Sterility, 47, 920, 10.1016/S0015-0282(16)59223-1 Chillik, 1987, Characterizing pituitary response to a gonadotropin-releasing hormone antagonist in monkeys: tonic follicle-stimulating hormone/luteinizing hormone secretion versus acute GnRH challenge tests before, during and after treatment, Fertility and Sterility, 48, 480, 10.1016/S0015-0282(16)59422-9 Dodson, 1989, Clinical characteristics of ovulation induction with human menopausal gonadotropins with and without leuprolide acetate in polycystic ovary syndrome, Fertility and Sterility, 52, 915, 10.1016/S0015-0282(16)53151-3 Dor, 1990, The treatment of polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility, Human Reproduction, 56, 816, 10.1093/oxfordjournals.humrep.a137189 Dubourdieu, 1993, The combination of gonadotrophin-releasing hormone (GnRH) antagonist and pulsatile GnRH normalize luteinizing hormone secretion in polycystic ovarian disease but fails to induce follicular maturation, Human Reproduction, 8, 2056, 10.1093/oxfordjournals.humrep.a137981 Filicori, 1984, Neuroendocrine regulation of the corpus luteum in the human: evidence for pulsatile progesterone secretion, Journal of Clinical Investigation, 73, 1638, 10.1172/JCI111370 Filicori, 1986, Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle, Journal of Clinical Endocrinology and Metabolism, 62, 1136, 10.1210/jcem-62-6-1136 Filicori, 1989, The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management, Journal of Clinical Endocrinology and Metabolism, 69, 825, 10.1210/jcem-69-4-825 Fleming, 1986, Induction of ovulation on polycystic ovarian disease, Progress in Clinical and Biological Research, 225, 401 Franks, 1988, Mechanism and management of ovulatory failure in women with polycystic ovary syndrome, Human Reproduction, 4, 531, 10.1093/oxfordjournals.humrep.a136739 Frydman, 1992, Spontaneous luteinizing hormone surges can be reliably prevented by the timely administration of a gonadotropin releasing hormone antagonist (Nal-Glu) during the late follicular phase, Human Reproduction, 7, 930, 10.1093/oxfordjournals.humrep.a137773 Gordon, 1990, A novel regimen of gonadotropin-releasing hormone antagonist plus pulsatile GnRH: controlled restoration of gonadotropin secretion and ovulation induction, Fertility and Sterility, 54, 1140, 10.1016/S0015-0282(16)54018-7 Hamilton-Fairley, 1991, Low dose gonadotropin therapy for induction of ovulation in 100 women with PCOS, Human Reproduction, 30, 154 Hoffman, 1993, Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotropin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle, Human Reproduction, 8, 695, 10.1093/oxfordjournals.humrep.a138122 Homburg, 1988, Influence of serum luteinising hormone concentration on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome, British Medical Journal, 297, 1024, 10.1136/bmj.297.6655.1024 Homburg, 1993, In vitro fertilization and embryo transfer for the treatment of patients with polycystic ovary syndrome, Fertility and Sterility, 60, 858, 10.1016/S0015-0282(16)56287-6 Johnson, 1990, Recurrent spontaneous abortion and polycystic ovarian disease: comparison of two regimens to induce ovulation, British Medical Journal, 300, 154, 10.1136/bmj.300.6718.154 Kazer, 1987, LH pulse frequency in women with PCO, Journal of Clinical Endocrinology and Metabolism, 65, 223, 10.1210/jcem-65-2-233 Lahlou, 1990, Changes in gonadotropin and alpha-subunit secretion after a single administration of gonadotropin-releasing hormone antagonist in adult males, Fertility and Sterility, 53, 898, 10.1016/S0015-0282(16)53529-8 Li, 1993, Is endometrial development in the preimplantation period influenced by high concentration of luteinising hormone in the follicular phase?, Human Reproduction, 8, 1021, 10.1093/oxfordjournals.humrep.a138186 Loumaye, 1997, Assessment of the role of luteinising hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome, Fertility and Sterility, 67, 889, 10.1016/S0015-0282(97)81402-1 Mortola, 1989, Suppression of bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone levels by a potent gonadotropin-releasing hormone antagonist: pharmacodynamic studies, Fertility and Sterility, 51, 957, 10.1016/S0015-0282(16)60725-2 Owen, 1989, The use of short regimen of buserilin, a GnRH agonist and human menopausal gonadotropin in assisted conception cycles, Human Reproduction, 4, 749, 10.1093/oxfordjournals.humrep.a136978 Regan, 1990, Hypersecretion of luteinising hormone, infertility, and miscarriage, Lancet, 336, 1141, 10.1016/0140-6736(90)92765-A Salat-Baroux, 1988, Comparison between long and short protocols of LHRH agonist in the treatment of polycystic ovary disease by in-vitro fertilization, Human Reproduction, 3, 535, 10.1093/oxfordjournals.humrep.a136740 Santen, 1973, Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanism, Journal of Clinical Investigation, 52, 2617, 10.1172/JCI107454 Schmutzler, 1988, Combinated GnRH agonist/gonadotropin stimulation for in-vitro fertilization, Human Reproduction, 3, 29, 10.1093/humrep/3.suppl_2.29 Sengoku, 1997, The chromosomal normality of unfertilized oocytes in polycystic ovarian syndrome, Human Reproduction, 12, 474, 10.1093/humrep/12.3.474 Stanger, 1985, Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinising hormone levels during the follicular phase, British Journal of Obstetrics and Gynaecology, 92, 385, 10.1111/j.1471-0528.1985.tb01113.x Surrey, 1989, Effects of gonadotropin-releasing hormone agonist on pituitary and ovarian responses to pulsatile GnRH therapy in polycystic ovarian disease, Fertility and Sterility, 52, 547, 10.1016/S0015-0282(16)60961-5 Takahashi, 1994, Transvaginal ultrasound imaging, histopathology, and endocrinopathy in patients with polycystic ovary syndrome, Human Reproduction, 9, 1231, 10.1093/oxfordjournals.humrep.a138684 Tarlatzis, 1997, The significance of high follicular phase luteinising hormone levels in the treatment of women with polycystic ovary syndrome, Journal of Assisted Reproduction and Genetics, 14, 1, 10.1007/BF02765740 Tarlatzis, 1995, The prognosis value of basal luteinising hormone: follicle-stimulating hormone ratio in the treatment of patients with polycystic ovary syndrome by assisted reproduction techniques, Human Reproduction, 10, 2545, 10.1093/oxfordjournals.humrep.a135742 Turhan, 1993, A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program, Journal of Assisted Reproduction and Genetics, 10, 15, 10.1007/BF01204435 Waldstreicher, 1988, Hyperfunction of the hypothalamic-pituitary axis in women with PCO, Journal of Clinical Endocrinology and Metabolism, 66, 165, 10.1210/jcem-66-1-165 Watson, 1993, Hypersecretion of luteinising hormone and ovarian steroid in women with recurrent early miscarriage, Human Reproduction, 8, 829, 10.1093/oxfordjournals.humrep.a138149 White, 1996, Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women, Journal of Clinical Endocrinology and Metabolism, 81, 3821, 10.1210/jc.81.11.3821